Full Text
The Full Text of this article is available as a PDF (88.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abelmann W. H. Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology. 1994 Nov;20(5):1356–1358. [PubMed] [Google Scholar]
- Angeli P., Albino G., Carraro P., Dalla Pria M., Merkel C., Caregaro L., De Bei E., Bortoluzzi A., Plebani M., Gatta A. Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology. 1996 Feb;23(2):264–273. doi: 10.1002/hep.510230211. [DOI] [PubMed] [Google Scholar]
- Angeli P., Volpin R., Gerunda G., Craighero R., Roner P., Merenda R., Amodio P., Sticca A., Caregaro L., Maffei-Faccioli A. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999 Jun;29(6):1690–1697. doi: 10.1002/hep.510290629. [DOI] [PubMed] [Google Scholar]
- Angeli P., Volpin R., Piovan D., Bortoluzzi A., Craighero R., Bottaro S., Finucci G. F., Casiglia E., Sticca A., De Toni R. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology. 1998 Oct;28(4):937–943. doi: 10.1002/hep.510280407. [DOI] [PubMed] [Google Scholar]
- Arroyo V., Ginès P., Gerbes A. L., Dudley F. J., Gentilini P., Laffi G., Reynolds T. B., Ring-Larsen H., Schölmerich J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996 Jan;23(1):164–176. doi: 10.1002/hep.510230122. [DOI] [PubMed] [Google Scholar]
- Faloon W. W., Eckhardt R. D., Murphy T. L., Cooper A. M., Davidson C. S. AN EVALUATION OF HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER. J Clin Invest. 1949 Jul;28(4):583–594. doi: 10.1172/JCI102108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Follo A., Llovet J. M., Navasa M., Planas R., Forns X., Francitorra A., Rimola A., Gassull M. A., Arroyo V., Rodés J. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994 Dec;20(6):1495–1501. doi: 10.1002/hep.1840200619. [DOI] [PubMed] [Google Scholar]
- Gentilini P., Casini-Raggi V., Di Fiore G., Romanelli R. G., Buzzelli G., Pinzani M., La Villa G., Laffi G. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol. 1999 Apr;30(4):639–645. doi: 10.1016/s0168-8278(99)80194-9. [DOI] [PubMed] [Google Scholar]
- Ginès A., Fernández-Esparrach G., Monescillo A., Vila C., Domènech E., Abecasis R., Angeli P., Ruiz-Del-Arbol L., Planas R., Solà R. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996 Oct;111(4):1002–1010. doi: 10.1016/s0016-5085(96)70068-9. [DOI] [PubMed] [Google Scholar]
- Ginès P., Titó L., Arroyo V., Planas R., Panés J., Viver J., Torres M., Humbert P., Rimola A., Llach J. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988 Jun;94(6):1493–1502. doi: 10.1016/0016-5085(88)90691-9. [DOI] [PubMed] [Google Scholar]
- Guevara M., Ginès P., Fernández-Esparrach G., Sort P., Salmerón J. M., Jiménez W., Arroyo V., Rodés J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology. 1998 Jan;27(1):35–41. doi: 10.1002/hep.510270107. [DOI] [PubMed] [Google Scholar]
- HECKER R., SHERLOCK S. Electrolyte and circulatory changes in terminal liver failure. Lancet. 1956 Dec 1;271(6953):1121–1125. doi: 10.1016/s0140-6736(56)90149-0. [DOI] [PubMed] [Google Scholar]
- Henriksen J. H., Winkler K. Transvascular escape rate of albumin in liver cirrhosis, and its possible role in formation of ascites. Scand J Gastroenterol. 1977;12(7):877–884. doi: 10.3109/00365527709181734. [DOI] [PubMed] [Google Scholar]
- Kunkel H. G., Labby D. H., Ahrens E. H., Shank R. E., Hoagland C. L. THE USE OF CONCENTRATED HUMAN SERUM ALBUMIN IN THE TREATMENT OF CIRRHOSIS OF THE LIVER. J Clin Invest. 1948 May;27(3 Pt 1):305–319. doi: 10.1172/JCI101959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lenz K., Hörtnagl H., Druml W., Reither H., Schmid R., Schneeweiss B., Laggner A., Grimm G., Gerbes A. L. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991 Oct;101(4):1060–1067. doi: 10.1016/0016-5085(91)90734-3. [DOI] [PubMed] [Google Scholar]
- Mankin H., Lowell A. OSMOTIC FACTORS INFLUENCING THE FORMATION OF ASCITES IN PATIENTS WITH CIRRHOSIS OF THE LIVER. J Clin Invest. 1948 Jan;27(1):145–153. doi: 10.1172/JCI101917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin P. Y., Ginès P., Schrier R. W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med. 1998 Aug 20;339(8):533–541. doi: 10.1056/NEJM199808203390807. [DOI] [PubMed] [Google Scholar]
- Møller S., Bendtsen F., Henriksen J. H. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology. 1995 Dec;109(6):1917–1925. doi: 10.1016/0016-5085(95)90759-9. [DOI] [PubMed] [Google Scholar]
- Navasa M., Rimola A., Rodés J. Bacterial infections in liver disease. Semin Liver Dis. 1997;17(4):323–333. doi: 10.1055/s-2007-1007209. [DOI] [PubMed] [Google Scholar]
- Patek A. J., Mankin H., Colcher H., Lowell A., Earle D. P. THE EFFECTS OF INTRAVENOUS INJECTION OF CONCENTRATED HUMAN SERUM ALBUMIN UPON BLOOD PLASMA, ASCITES AND RENAL FUNCTIONS IN THREE PATIENTS WITH CIRRHOSIS OF THE LIVER. J Clin Invest. 1948 Jan;27(1):135–144. doi: 10.1172/JCI101916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roberts J. S., Bratton S. L. Colloid volume expanders. Problems, pitfalls and possibilities. Drugs. 1998 May;55(5):621–630. doi: 10.2165/00003495-199855050-00002. [DOI] [PubMed] [Google Scholar]
- Runyon B. A. Historical aspects of treatment of patients with cirrhosis and ascites. Semin Liver Dis. 1997;17(3):163–173. doi: 10.1055/s-2007-1007195. [DOI] [PubMed] [Google Scholar]
- Schrier R. W., Arroyo V., Bernardi M., Epstein M., Henriksen J. H., Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988 Sep-Oct;8(5):1151–1157. doi: 10.1002/hep.1840080532. [DOI] [PubMed] [Google Scholar]
- Schrier R. W., Niederberger M., Weigert A., Ginès P. Peripheral arterial vasodilatation: determinant of functional spectrum of cirrhosis. Semin Liver Dis. 1994 Feb;14(1):14–22. doi: 10.1055/s-2007-1007294. [DOI] [PubMed] [Google Scholar]
- Sort P., Navasa M., Arroyo V., Aldeguer X., Planas R., Ruiz-del-Arbol L., Castells L., Vargas V., Soriano G., Guevara M. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999 Aug 5;341(6):403–409. doi: 10.1056/NEJM199908053410603. [DOI] [PubMed] [Google Scholar]
- WILKINSON P., SHERLOCK S. The effect of repeated albumin infusions in patients with cirrhosis. Lancet. 1962 Dec 1;2(7266):1125–1129. doi: 10.1016/s0140-6736(62)90895-4. [DOI] [PubMed] [Google Scholar]
- Witte M. H., Witte C. L., Dumont A. E. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology. 1971 Nov;61(5):742–750. [PubMed] [Google Scholar]
- Wong P. Y., Carroll R. E., Lipinski T. L., Capone R. R. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion. Gastroenterology. 1979 Dec;77(6):1171–1176. [PubMed] [Google Scholar]